2024 ICD-10-CM Diagnosis Code D04.122

Carcinoma in situ of skin of left lower eyelid, including canthus

ICD-10-CM Code:
D04.122
ICD-10 Code for:
Ca in situ skin of left lower eyelid, including canthus
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

D04.122 is a billable diagnosis code used to specify a medical diagnosis of carcinoma in situ of skin of left lower eyelid, including canthus. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Bowen's disease of eyelid
  • Carcinoma in situ of skin of eyelid
  • Intraepidermal squamous carcinoma of face
  • Squamous cell carcinoma in situ of skin of left lower eyelid

Clinical Classification

Replacement Code

D04122 replaces the following previously assigned ICD-10-CM code(s):

  • D04.12 - Carcinoma in situ of skin of left eyelid, including canthus

Patient Education


Skin Cancer

Skin cancer is the most common form of cancer in the United States. The two most common types are basal cell cancer and squamous cell cancer. They usually form on the head, face, neck, hands, and arms. Another type of skin cancer, melanoma, is more dangerous but less common.

Anyone can get skin cancer, but it is more common in people who :

  • Spend a lot of time in the sun or have been sunburned
  • Have light-colored skin, hair and eyes
  • Have a family member with skin cancer
  • Are over age 50

You should have your doctor check any suspicious skin markings and any changes in the way your skin looks. Treatment is more likely to work well when cancer is found early. If not treated, some types of skin cancer cells can spread to other tissues and organs. Treatments include surgery, radiation therapy, chemotherapy, photodynamic therapy (PDT), and biologic therapy. PDT uses a drug and a type of laser light to kill cancer cells. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.